Serial GH Measurement After Intravenous Catheter Placement Alone Can Detect Levels Above Stimulation Test Thresholds...

Area of Science:

• Pediatric Endocrinology
• Growth Hormone Physiology
• Diagnostic Testing

Background:

• Growth hormone (GH) stimulation testing often lacks specificity and reproducibility for diagnosing GH deficiency.
• Intravenous line placement (IVP) may inadvertently stimulate GH secretion in pediatric patients.

Purpose of the Study:

• To assess if measuring GH levels post-IVP identifies additional children with sufficient peak GH concentrations.
• To compare GH levels after IVP with those obtained during a subsequent insulin tolerance test (ITT).

Main Methods:

• Modified the insulin tolerance test (ITT) protocol to include GH measurements at baseline (t=0), 15 minutes (t=15), and 30 minutes (t=30) after IVP.
• Administered insulin at t=30 minutes for a standard ITT.
• Grouped 97 pediatric patients based on the indication for testing: initial GH deficiency evaluation (group 1) or transition to adulthood (group 2).

Main Results:

• 27% of patients (19 in group 1, 8 in group 2) achieved a peak GH concentration of ≥7 ng/mL after either IVP or ITT.
• 13 patients (11 in group 1, 2 in group 2) showed adequate GH response to IVP but not to ITT.
• In group 1, GH peaks ≥7 ng/mL occurred at t=0, t=15, and t=30 minutes post-IVP, with one patient responding at all time points.

Conclusions:

• Some children exhibit a robust GH response to IVP, even without responding adequately to pharmacological stimuli.
• Recommends measuring GH levels following IVP in children undergoing GH stimulation testing.
• This approach is particularly valuable when delays occur between IVP and the administration of pharmacological agents.